BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Adami G, Saag KG, Chapurlat RD, Guañabens N, Haugeberg G, Lems WF, Matijevic R, Peel N, Poddubnyy D, Geusens P. Balancing benefits and risks in the era of biologics. Ther Adv Musculoskelet Dis 2019;11:1759720X19883973. [PMID: 31695755 DOI: 10.1177/1759720X19883973] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Reid DM. Balancing the risks and benefits of biologic drugs in rheumatic disease: the case for romosozumab? Ther Adv Musculoskelet Dis 2020;12:1759720X19895490. [PMID: 32010237 DOI: 10.1177/1759720X19895490] [Reference Citation Analysis]
2 Ballhause TM, Jiang S, Baranowsky A, Brandt S, Mertens PR, Frosch KH, Yorgan T, Keller J. Relevance of Notch Signaling for Bone Metabolism and Regeneration. Int J Mol Sci 2021;22:1325. [PMID: 33572704 DOI: 10.3390/ijms22031325] [Cited by in F6Publishing: 2] [Reference Citation Analysis]